Skip to content
Recall Observatory FDA recall evidence

Drug product

Dr. Reddy's Ranitidine Tablets, USP 75 mg, 60 count bottles, NDC 55111-131-60, (OTC)

D-0181-2020

October 01, 2019

Class II

Product summary

Firm
Dr. Reddy's Laboratories, Inc.
Event
Event 83908
Status
Completed
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-0181-2020

Official wording

Reason: CGMP Deviations: Presence of NDMA impurity detected in product.

Code information: Batch Numbers: All lots within expiry.

Distribution pattern: Product was distributed to major distributors throughout the United States who may have further distributed the product.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    NDMA impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations